The EDC is live today — see what ships now
All studies
NCT05741697From ClinicalTrials.govRecruiting

HFNC in Management of Bronchiectasis Exacerbation

High Flow Nasal Cannula Versus Non-invasive Ventilation in Managing Acute Exacerbation of Bronchiectasis Patients

  • Bronchiectasis

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
Assiut University
Enrolment target
20
Started
1 March 2023
Main results due
1 November 2026
Study sites
1
Registry updated
24 September 2026

Can you take part?

  • Ages 18 years to 80 years.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Patients will be eligible for enrolment if diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU), requiring ventilator support without invasive mechanical ventilation.

Exclusion Criteria:

* Age: less than 18 years. Patients with post-arrest encephalopathy. Patient with the previous tracheotomy. Patients who received invasive ventilatory support. Patients with end-organ failure.

What this study is about

In the sponsor’s own words, from the registry.

Patients with Bronchiectasis experience exacerbations with hypercapnic respiratory failure associated with an increased respiratory workload that may require intensive care unit (ICU) admission due to the inability of the respiratory muscles to compensate for increased demand. These exacerbations are frequently treated with noninvasive ventilation (NIV).

Study sites(1)

  • Assiut University-Faculty of medicine

    Asyut, Egypt

    Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT05741697. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
HFNC in Management of Bronchiectasis Exacerbation | Trialion